- This event has passed.
Diabetes and Audiological Monitoring of Ototoxic/Vestibulotoxic Medications
June 26, 2018 @ 12:30 pm - 1:30 pm
Presenter: Robert M. DiSogra, AuD, FAAA and Michelle B. Mcelhannon, PharmD.
The association between diabetes and hearing loss continues to be unrecognized by many health care practitioners. Diabetes is a complex disease state requiring a multi-faceted approach to management. The ABCs of diabetes treatment will be presented, as will be the approach to managing common complications. With complicated disease states comes complicated medication regimens. Recognition and management of the barriers to adherence in diabetic patients will be outlined. There are at least 59 prescription medications (including oral and injectables) for patients with diabetes that have auditory, vestibular and/or cognitive side effects. Not knowing which medications have these side effects could lead to inappropriate recommendations thus leading to management errors. The 2nd half will review the signs and symptoms of hearing loss in adults and who is considered “at risk.” There will be a review of the diabetes medications that could cause any one or all of these side effects. There will be a discussion about the importance of audiometric testing for Type II diabetes patients as well as for patients who might be “at risk” for diabetes.
For info, email@example.com